Results 41 to 50 of about 925 (175)
Journal of Evidence-Based Medicine, Volume 16, Issue 4, Page 565-580, December 2023., 2023 Abstract Chronic obstructive pulmonary disease (COPD), with high prevalence rate, mortality, disability rate, and heavy disease burden, has become a critical chronic disease seriously threatening public health worldwide. Traditional Chinese medicine and Western medicine both have shown advantages in diagnosing and treating COPD, which has been widely ...
Jiansheng Li +3 more
wiley +1 more source
Xuebijing injection in the treatment of COVID-19: a retrospective case-control study [PDF]
Annals of Palliative Medicine, 2020 Neither a vaccine nor specific therapeutic drugs against 2019 novel coronavirus have been developed. Some studies have shown that Xuebijing injection (XBJ) can exert an anti-inflammatory effect by inhibiting the production of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and other cytokines.
Hu, Guo +13 more
openaire +2 more sources
Development of radiation countermeasure agents for acute radiation syndromes
Animal Models and Experimental Medicine, Volume 6, Issue 4, Page 329-336, August 2023., 2023 Developments of radiation countermeasure agents for the acute radiation syndromes. Exposure to ionizing radiation induced direct or indirect damage effects on molecules, cells, tissues and organs of the body. A number of radiation countermeasure agents that are currently under different status of development and target the core mechanisms of radiation ...
Bowen Guan, Deguan Li, Aimin Meng
wiley +1 more source
Diagnosis and treatment protocol for COVID‐19 patients (Tentative 10th Version)
Health Care Science, Volume 2, Issue 1, Page 10-24, February 2023., 2023 Abstract To further improve the diagnosis and treatment of COVID‐19, the National Health Commission of People's Republic of China and the National Administration of Traditional Chinese Medicine convened a group of experts to revise the relevant content of the Diagnosis and Treatment Protocol for COVID‐19 Patients (Trial Version 9) and developed the ...
Released by National Health Commission of People's Republic of China & National Administration of Traditional Chinese Medicine on January 5 +1 more
wiley +1 more source
Scientific Reports, 2021 Traditional Chinese medicine (TCM) injection is widely used in clinical settings, but its adverse drug reactions (ADRs) can be a serious public health concern. The objective is to study the safety of TCM injection and provide suggestions for clinical use.
Rui Huang +5 more
doaj +1 more source
Frontiers in Surgery, 2022 ObjectiveTo investigate the efficacy of xuebijing combined with ulinastatin in the treatment of traumatic sepsis and analyze the effects on inflammatory factors and immune function of patients.Methods182 patients with traumatic sepsis were selected from ...
Yuanchao Su +3 more
doaj +1 more source
Guideline on treating community-acquired pneumonia with Chinese patent medicines
Pharmacological Research, 2023 Community-acquired pneumonia (CAP) is one of the most common infectious diseases, and its morbidity and mortality increase with age. Resistance and mutations development make the use of anti-infective therapy challenging.
Minghang Wang +12 more
doaj +1 more source
Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019 [PDF]
Chinese Journal of Natural Medicines, 2020 Jing Shang, Jun Liao
exaly +2 more sources
TCM2COVID: A resource of anti‐COVID‐19 traditional Chinese medicine with effects and mechanisms
iMeta, Volume 1, Issue 4, December 2022., 2022 TCM2COVID documents over 280 traditional Chinese medicine formulas (including over 300 herbs) with detailed clinical evidence and therapeutic mechanism information; TCM2COVID records over 80 natural products with detailed potential therapeutic mechanisms; TCM2COVID launches a useful web server for querying, analyzing, and visualizing documented ...
Liping Ren +9 more
wiley +1 more source
Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)
Health Care Science, Volume 1, Issue 1, Page 14-28, August 2022., 2022 Abstract To further improve the diagnosis and treatment of COVID‐19, China National Health Commission and the National Administration of Traditional Chinese Medicine convened a group of experts to revise the relevant content of the Diagnosis and Treatment Protocol for COVID‐19 Patients (Trial Version 8) and developed the Diagnosis and Treatment ...
Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15 +1 more
wiley +1 more source